MEI Pharma, a United States pharmaceutical company, has made history as the first publicly traded firm to adopt Litecoin (LTC) as a primary treasury reserve asset. The company announced today that it purchased 929,548 LTC, worth $100 million.
A Historic Litecoin Treasury Move
The acquisition was made through a well-structured private investment in public equity (PIPE) deal valued at $100 million, led by notable figures in the crypto ecosystem, including Litecoin’s creator, Charlie Lee, and crypto investment firm GSR.
A team of other crypto-focused entities, including Mozayyx, ParaFi, Hivemind, CoinFund, and the Litecoin Foundation, supports this funding initiative, showing a united front in the institutional adoption of cryptocurrency.
Charlie Lee, who is an influential voice on social media platforms like X, has taken an important role by joining MEI’s Board of Directors to provide strategic guidance throughout this venture.
Why the Shift to Litecoin?
MEI chose Litecoin for its 13-year history of reliable performance, low transaction fees, and fast settlement times. Created in 2011 as a Bitcoin alternative, Litecoin is a decentralized, open-source crypto designed for quick, low-cost payments without needing a bank.
Its widespread acceptance on platforms like BitPay, Robinhood, PayPal, and Venmo further supports the company’s decision, highlighting Litecoin’s established role in the crypto market.
The pharmaceutical company plans to deepen its involvement with Litecoin, potentially exploring crypto mining while it continues its medical research, particularly on voruciclib, which is an investigational drug. MEI Pharma’s adoption of Litecoin shows a growing trend of companies adding digital assets to their financial strategies.
For example, Singapore-based crypto mining firm Bit Origin recently established a $500 million Dogecoin (DOGE) treasury. The capital raise, which comprises $400 million in Class A shares and $100 million in convertible debt, aims to create a public Dogecoin (DOGE) treasury.
Similarly, BitMine Immersion Technologies recently unlocked a major milestone. The firm raised $2 billion in support for an ETH treasury, which brought significant visibility to the trend among publicly traded firms. However, MEI Pharma’s strategic focus on Litecoin introduces a new approach, showing the potential for alternative digital assets to change the future of corporate asset management.
Find Cryptocurrencies to Watch and Read Crypto News on the Go Follow CryptosToWatch on X (Twitter) Now
